What Is the Difference Between Chronic Sinusitis and Recurrent Sinus Infections?

Short answer: Chronic rhinosinusitis (CRS) is a prolonged inflammatory condition of the nose and sinuses lasting more than 12 weeks — driven by persistent mucosal inflammation that may or may not involve active infection, sometimes with acute worsening called an exacerbation, but never fully resolving between episodes. Recurrent acute rhinosinusitis (RARS) is a pattern of four or more distinct sinus infections per year where the patient completely recovers between episodes. These two conditions look similar during a flare but are fundamentally different diseases requiring different treatment strategies. Getting the diagnosis right changes everything.

By Dr. Franklyn R. Gergits, MBA, DO, FAOCO · Board-Certified Otolaryngologist · Fellowship-Trained Otolaryngic Allergist · Clinical Focus in Rhinology and Airway Disorders · 30+ Years of Experience · Founder, Sinus & Allergy Wellness Center of North Scottsdale

The Question That Changes the Entire Treatment Plan

When a patient comes in telling me they keep getting sinus infections — that this has been going on for years, that antibiotics help temporarily but it always comes back — the first question I ask is not which antibiotic they have been on. The first question is: what happens between the episodes?

That answer tells me almost everything I need to know.

If the answer is “I feel completely normal between episodes” — that is one clinical picture. If the answer is “it gets better but my better is still not normal — it is always there, sometimes it just gets really bad” — that is an entirely different diagnosis, an entirely different disease process, and an entirely different treatment pathway.

Most patients who come to SAWC after years of recurrent sinus problems have never been asked that question in quite that way. And most of them have never had their answer lead to a diagnosis that changed what happened next.

What Is Chronic Rhinosinusitis?

Chronic rhinosinusitis is a prolonged inflammatory condition of the nose and sinuses — not simply a prolonged infection. By definition it lasts more than 12 weeks. The inflammation may be associated with infection, but it does not have to be — and this is where the confusion starts, because most patients assume that sinusitis always means infection and infection always means antibiotics.

CRS patients have a baseline level of mucosal inflammation that never fully resolves. Between their worst days and their better days, there is still something there — congestion, pressure, drainage, smell loss. Their “normal” is not actually normal. They have adjusted to a chronic low-grade state of sinonasal disease and stopped recognizing it as disease.

Within the CRS category there is an important subset called acute exacerbation of chronic rhinosinusitis — AECRS. This is when a CRS patient suddenly gets significantly worse. Their baseline inflammation flares into something more acute — increased pressure, increased drainage, sometimes fever, sometimes severe facial pain. These episodes can look exactly like a new sinus infection. They are not. They are a flare of an existing chronic disease. Treating them only with a course of antibiotics and sending the patient home misses the underlying chronic process entirely.

What Is Recurrent Acute Rhinosinusitis?

Recurrent acute rhinosinusitis is a different animal. RARS patients get four or more distinct episodes of acute sinusitis per year. During each episode they have the full constellation of symptoms — facial pressure and pain, significant congestion, thick post-nasal drainage, and sometimes decreased sense of smell, ear pressure, fatigue, halitosis, or even dental pain from pressure on the upper tooth roots.

But between those episodes? They feel completely normal. Not a little better — genuinely normal. The sinuses clear, the pressure resolves, the drainage stops. They return to baseline. And then, weeks or months later, it starts again.

This pattern — recurrent acute episodes with full recovery in between — is the defining clinical feature of RARS. It is also why RARS patients are frequently undertreated. Because they feel fine between episodes, the urgency of evaluation decreases. Because each episode responds to antibiotics, it looks like the problem is being managed. And because no one has connected the dots across four or six or eight episodes in a year, the underlying structural or mucosal vulnerability driving the recurrence never gets addressed.

Why the Distinction Matters Clinically

These two conditions are distinctly different clinically — and the treatment implications are significant.

CRS patients tend to have more severe and more persistent mucosal inflammation. On a CT scan taken even between acute flares, you will typically see mucosal thickening, opacification, or inflammatory changes in one or more sinuses. The disease is always there — you just see more of it during an exacerbation. CRS patients often require a combination of medical management of upstream triggers and procedural intervention to restore drainage and reduce the inflammatory burden the medication cannot reach.

RARS patients may show a completely normal CT scan between episodes. The workup for RARS specifically includes evaluation for anatomic variants predisposing to recurrent obstruction, allergy testing, and immunologic evaluation — a different diagnostic pathway than CRS management alone. The sinus cavities clear. Mucociliary function restores. And yet they keep getting hit. For RARS patients, the goal is to identify and correct whatever structural vulnerability or mucosal priming is making them susceptible to repeated acute events. Once accurately diagnosed and treated — whether with targeted medical therapy, procedural intervention, or both — many RARS patients can dramatically reduce or eliminate their episode frequency. They can often be treated more definitively once the root cause is identified.

The One Thing Patients Say That Tells Me Which Category They Are In

When I am taking a history from a patient with recurrent sinus problems, there is one response that immediately tells me I am looking at CRS rather than RARS.

They say: “It is always there. Sometimes it gets really bad — to the point where it is debilitating — and then it gets better. But my better is not normal. My better is still congested. I still have drainage. I still have some pressure. I just have less of it.”

That statement — “my better is not normal” — is the clinical tell. That patient has CRS. Their baseline has shifted. They have adapted to living at a level of sinonasal inflammation that is frankly abnormal and they no longer recognize it as disease because it has become their daily experience.

The RARS patient says something different: “Between my infections I feel completely fine. I play tennis, I sleep perfectly, I have no congestion. And then it hits me again out of nowhere.”

Both patients need evaluation. Both need treatment. And there is an important warning embedded in the RARS story: what started as separate infections can, over time, become one continuous problem — especially when the same antibiotics are used repeatedly, resistant bacteria emerge, and biofilm forms in the sinus cavities. Early accurate diagnosis is not just academic. It is what prevents RARS from quietly converting into CRS. But the evaluation looks different, the imaging is interpreted differently, and the treatment pathway is different. Starting with the right diagnosis is everything.

What Happens at SAWC When You Come In

When a patient presents to SAWC with a history of recurrent sinus problems, we do not reach for a prescription pad. We build a complete clinical picture — CT imaging when indicated, nasal endoscopy, a detailed history including symptom frequency, antibiotic history, prior treatment response, and upstream triggers. We obtain a SNOT score to quantify the symptom burden. And when clinically appropriate, we obtain a specimen for MicroGenDX next-generation sequencing so we know exactly what organisms are active — not what we guess might be there based on prior culture results or antibiotic selection.

The goal on visit one is not to prescribe. The goal is to reach a definitive diagnosis so that the treatment plan we recommend is targeted, evidence-based, and — where possible — curative rather than suppressive.

Because the difference between CRS and RARS is not just academic. It determines whether you need a procedure. It determines whether you need immunotherapy. It determines whether there is an upstream driver — reflux, allergy, posterior sinonasal inflammation — that has never been identified. And it determines whether four more courses of antibiotics this year will help you or simply accelerate the resistance problem that is making future treatment harder.

Dr. G’s Pearls

▸ “My better is not normal” is the clinical tell for CRS. If you still have congestion, drainage, or pressure between your acute flares — that is not baseline. That is chronic disease. It deserves evaluation, not acceptance.

▸ RARS patients feel completely normal between episodes — but the vulnerability is always there. Four infections per year is not bad luck. It is a signal that something structural or mucosal is creating the conditions for repeated acute events. Find it and fix it.

▸ A normal CT between episodes does not rule out RARS. RARS sinuses can clear completely between episodes. A normal scan between infections does not mean there is no problem. It means you caught the patient on a good day.

▸ The AECRS patient looks like a new infection — but is not. Treating every acute exacerbation of CRS as a new infection misses the chronic disease underneath. The antibiotics may reduce the acute flare. They will not resolve the baseline mucosal inflammation driving it.

▸ The right diagnosis on visit one changes everything that follows. CRS and RARS require different workups, different imaging interpretations, different treatment targets, and often different procedures. Getting the diagnosis right is not a formality — it is the foundation of everything.

Want to Understand More?

Why Antibiotics Keep Failing Your Sinus Infection

What Is MicroGenDX and Why Does It Change Everything About Sinus Treatment?

What Is Balloon Sinuplasty — And Are You a Candidate?

My Doctor Recommended Multiple Procedures — Is That Too Much for One Visit?

Can Sinus Infections Cause Brain Fog?

About the Author

Dr. Franklyn R. Gergits, MBA, DO, FAOCO is a Board-Certified Otolaryngologist and Fellowship-Trained Otolaryngic Allergist with a Clinical Focus in Rhinology and Airway Disorders and over 30 years of clinical experience. He is the founder of the Sinus & Allergy Wellness Center of North Scottsdale, where he performs in-office balloon sinuplasty, turbinate reduction, NEUROMARK® posterior nasal nerve ablation (Neurent Medical, FDA-cleared radiofrequency ablation system), and Eustachian tube dilation under local anesthesia. He performed the first balloon sinuplasty in Pennsylvania and holds dual Entellus Centers of Excellence certifications. Dr. Gergits is the originator of the Posterior Sinonasal Syndrome (PSS) hypothesis — a clinical framework identifying pepsin-mediated posterior nasal mucosal injury as an upstream driver of chronic rhinosinusitis. Preprint available at Preprints.org (DOI: 10.20944/preprints202603.0858.v1). ORCID: 0009-0000-4893-6332.

SinusAndAllergyWellnessCenter.com · 480-525-8999

This content is for educational purposes only and does not constitute medical advice. If you have been experiencing recurrent sinus infections or persistent sinus symptoms, please consult a qualified otolaryngologist for evaluation and individualized diagnosis and treatment recommendations.